Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models

Source: Acta Neuropathologica - Category: Neurology Source Type: research
More News: Alzheimer's | Brain | Neurology